Xcout Intel
Phase Genomics, Inc.
Phase Genomics, Inc. is headquartered in Seattle, Washington, and provides ultra-long-range sequencing solutions and Hi-C technologies. The company supports genomic research and applications through its specialized laboratory products and services.
Subscribe to see Phase Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phase Genomics, Inc. at a glance
Phase Genomics, Inc. is a biotechnology company headquartered in United States. It has raised at least $7.3M across the 3 funding rounds on record. Its most recent funding round, Grant, raised $1.5M in March 2024. Xcout tracks 3 named people at Phase Genomics, Inc., including Kayla Young (COO).
Phase Genomics, Inc. leadership
- Kayla YoungCOO
- Ivan LiachkoFounder & CEO
- Stephen EackerVP of Research & Development
Phase Genomics, Inc. funding rounds
At least $7.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $1.5M | 4 named | |
| SEC Form D filing | $4.8M | — | |
| SEC Form D filing | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Phase Genomics, Inc. competitors
A few of Phase Genomics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Paragon Genomics is a precision medicine company headquartered in Fremont, California. The company develops and commercializes patented targeted sequencing and breakthrough target enrichment solutions for researchers and clinical applications.
ArgenTAG Corporation is a biotechnology company specializing in high-resolution single-cell long-read sequencing solutions. Headquartered in New York, New York, the company develops innovative genomic tools for life sciences research.
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Pacific Biosciences of California, Inc. is a global life sciences technology company headquartered in Menlo Park, California, that develops genetic sequencing systems.
Arima Genomics is a biotechnology company headquartered in San Diego, California. The company leverages whole-genome sequence and three-dimensional genomic structure information to advance life science research and cancer therapy.
Ultima Genomics is a company headquartered in Fremont, California, with 100-1000 employees. Its mission is to continuously drive the power of genomics, operating in the AI, Biotech/Pharma, and Life Sciences sectors.
Get Phase Genomics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Phase Genomics, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access